Acalabrutinib shows less off-target activity in mantle cell lymphomaMarch 2, 2018Aggressive Lymphomas
NF-kappaB pathway could help solve resistance problem in mantle cell lymphomaFebruary 16, 2018Aggressive Lymphomas